SCHEMBL6568665

SCHEMBL6568665

O=C(Cc1ccc(O)c(Cl)c1)N1CCCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.60
CA2 P00918 3/20 0.58
ECE2 P0DPD6 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 2/20 0.54
HPGD P15428 1/20 0.54
POLB P06746 1/20 0.54
MEN1 O00255 1/20 0.50
CA1 P00915 2/20 0.49
LMNA P02545 1/20 0.49
SIGMAR1 Q99720 2/20 0.48
MAPT P10636 1/20 0.48
HSD17B2 P37059 1/20 0.47
HSP90AA1 P07900 1/20 0.46
OPRK1 P41145 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
NFKB1 P19838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567577 0.98 KMT2A (0.58) KMT2ACA2ECE2SMN1; SMN2NPC1
SCHEMBL13825973 0.82 SIGMAR1 (0.52) KMT2ACA2CA1SIGMAR1OPRK1
SCHEMBL16002874 0.81 SIGMAR1 (0.54) KMT2ACA2SMN1; SMN2CA1SIGMAR1
SCHEMBL6565612 0.81 HPGD (0.53) KMT2AECE2SMN1; SMN2NPC1HPGD
SCHEMBL6565694 0.80 SMN1; SMN2 (0.56) KMT2AECE2SMN1; SMN2NPC1HPGD
SCHEMBL7430480 0.78 HPGD (0.67) KMT2ASMN1; SMN2NPC1HPGDPOLB
SCHEMBL17509110 0.78 CA2 (0.42) KMT2ACA2ECE2SMN1; SMN2NPC1
SCHEMBL12988833 0.78 ECE2 (0.51) KMT2AECE2SMN1; SMN2NPC1HPGD
SCHEMBL5088782 0.78 ECE2 (0.55) KMT2AECE2SMN1; SMN2NPC1HPGD
SCHEMBL13216174 0.78 HSD11B1 (0.57) KMT2AECE2SMN1; SMN2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed